8/9/2019 Areej Data

1/14

I

: C . HEB .H I AL

: A A H

. : C : .D A :52 A :11/11/2014 G : :

I D :C :11/11/2014 A :

M :

:1. :

E : 8H CLA : E :

2. :

: 4 :5 :2 : :

: D , :

,

D : . . E : . : 8

8/9/2019 Areej Data

2/14

:

2 , 1 ,

GB , .

:2 ,

, 1 , / GB

, .

:

.

.

: ( 64 / ); .: 36 C : 16 B /

B : (126/78 H )

: , , ,

, , , . & :

160 78 ,BMI= 78 /(1.6) 2 = 30 :

, .

: B ,

, , .H .

: , .

A ; .

, , , ' '

, , .

8/9/2019 Areej Data

3/14

8/9/2019 Areej Data

4/14

( )

1. : / , /

:

C , ( )F , . A ( , )F .

2. : I : , .

.

: .

3. : :

I , , , , . L , / .

4. : : .

H / .

8/9/2019 Areej Data

5/14

H % 13.3 / 12 16 /BC 4.3 / 3 4 5.3 / 3 BC 6500 / 3 4500 11000/ 3 L 238*10 3 / 3 (150 350)*10 3 / 3

C A

H A A

B

E BC

B 11 / 10 20 / C 0.8 / 0.7 1.4 / AL ( G ) 24 / 4 36 / I 1FB 92 / 70 126 /

: :

G 3.4 * 2

8/9/2019 Areej Data

6/14

MDrug Name Drug Name Drug Name Drug Name& Dose & Dose & Dose & Dose

Rational Rational Rational Rational Action Action Action Action Side effectSide effectSide effectSide effect NSG Implications NSG Implications NSG Implications NSG Implications

Ceftriaxone(Cephalosporin3rd generation)T

(Rocephin)1g X 2Rout :IVTime6am 6 pm

For treatment ofinfection becauseits broadspectrumantibiotic andculture testsensitive

antibiotics forACUTEBACTERIALInfectionaffecting the cellwall of bacteria,Rocephin helpskill bacteria(

Pain, warmth,and/or minorswelling atinjection site,Unexplainedrash ,DiarrheaIncrease in liverenzymes

1. Observe for signs ofadverse reactions orHypersensitiviy tocephalosporins2. Monitor renal, hepatic,hematopoietic functions3. IV administration:Infusion over 30 minutes.

metronidazoleT

(Flagyl)

500 mg X 3

Rout :IVtime6am 2pm10pm

used to treatbacterialinfectionsparticularly foranaerobic

bacteria andprotozoa,and prophylacticpost op

It inhibits nucleicacid synthesis bydisrupting theDNA of microbialcells.

nausea, diarrhoea,weight loss,abdominal pain,vomiting,headache,

dizziness, andmetallic taste inthe mouth.

Monitor for S&S of:hepatotoxicity, even withmoderate doses,Avoid use unlessnecessary. Metronidazole

is carcinogenic in somerodents.Administer oral doses

with food.Apply topically aftercleansing the area.Advise patient thatcosmetics may be usedover the area afterapplication.Reduce dosage in hepaticdisease.

RanitidinehydrochlorideT(Ratidine)50 mg X 3Rout :IVTime6am 2pm10pm

Decreases theheart pain causeby high amountof HCl

Decreases amountof HCl produced bstomach byblocking action ofhistamine onhistamine receptorsof parietal cells inthe stomach

headache, nausea,fatigue, , dizziness

Administer oral drugwith meals and hs.Decrease doses in renaland liver failure.Administer IM doseundiluted, deep into largemuscle group.

PethidineT(Dolestine)

50 mg PRN

Rout :IV

synthetic opioidanalgesic for thetreatment of

moderate tosevere pain

Acting as an agonistat the -opioidreceptor.

nausea, vomiting,sedation, dizzinessdiaphoresis,urinary retentionand constipation.

Administer to lactatingwomen 46 hr before thenext feeding to minimizethe amount in milk.Keep opioid antagonistand facilities for assistedor controlled respirationreadily available duringparenteral administration.

8/9/2019 Areej Data

7/14

.

( ) . , 0% 0% .

. . ( ), ( . .

, .

, , , A I, , , . M

.

. I C ( ), , .

. M . A , , , ,

.

> 85% . F , :

B . ,

( ) ( , )

( , ).

. , ,

. .

.

, C C ( , C , C ). F

, , .

8/9/2019 Areej Data

8/14

, ). , ,

A ).

G 1 2 / , 5 20 . M ,

. G , ,

A 80% .

( ) . B .

. H , , , ,

. B . I ,

. E , 15 1 , ( ) 12 ( 12 , , .

G . A ;

. C , M I (M I), ( , ) . E

(< 3 )

8/9/2019 Areej Data

9/14

L ; , .

A , . A 10 15%

.

2%/ .

. , ; / , 1 2% /

, , .

F : L

F : E

M , , . H ,

, ( ) .

.

, . I 0.1%

.

L . , . ,

, , .L 2 5%

.

C . C . ,

.

8/9/2019 Areej Data

10/14

(> 3 ( ); .

F ( ,

), .

, ( ) (

).

4 5 / 3 / (8 10 / / ) 80% < 0.5 6 . F ( ),

, . F , , 50% 5 . M

. H , 300

.

( ) .

8/9/2019 Areej Data

11/14

/ . / . /

/ /

NURSING CARE PLAN NURSING CARE PLAN NURSING CARE PLAN NURSING CARE PLAN

8/9/2019 Areej Data

12/14

C . A . , . , , ,

. .

:

Instructions For Care Following cholecystectomy

: : I , , , .

. C . . , ,

: C . ,

.

: . A . D

. .

: .

o L . A . B , , .

o D . .

o . .

L . . , ,

. . K 2 . , . . , , . I ,

. D , , , 2 .

D 10 4 6 . I 10 2 3 . C .

. 1 . .

8/9/2019 Areej Data

13/14

. I

A . E . I 6 8 (8 .) . A 4 . A 4 (2 ).

( ) (M , .). F.

:

. , , . ( ) ( .(

. , , .

.

, , .

:

( .( . . . , .

, , . . . .

. , , . I . .

8/9/2019 Areej Data

14/14

References

1. Brunner & Suddarth's Textbook of Medical - Surgical Nursing (11th edition)Philadelphia: Lippincott Williams & Wilkins(2009).

2. Kozier & Erb's Fundamentals of Nursing Concepts, Process, and Practice(7th edition) (2007)

3. Amy M. Karch lippincott's nursing drug guide: Lippincott Williams &Wilkins (2009).

4. Bates Instructors Manual Guide to Physical Exam and History Taking (8 thedition) Philadelphia: Lippincott Williams & Wilkins(2006).

5. Meg Gulanick, Judith L. Myers Nursing Care Plans : Nursing Diagnosis and Intervention (6th edition) : Elsevier Health Sciences (2006)